Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.

Pharmaceutical

Siegfried Holding

Wolfgang Wienand

Dr Sreedhar Eppakayala

Noemi Debole

Srinavya Vutukuru

Sean Quinlivan

Jennifer Gómez

Peter Stierli

Henrik Krüpper

Irene Wosgien

Reto Suter

Marianne Späne

Marcel Imwinkelried

The Quality Assurance and Control team at Siegfried Holding ensures that all drug manufacturing processes adhere to stringent regulatory standards and quality specifications. This team conducts thorough reviews and testing of both active pharmaceutical ingredients and final drug products, implementing quality protocols and best practices to ensure safety, efficacy, and compliance. Their expertise spans quality assurance, quality control analysis, and regulatory compliance, ultimately safeguarding the integrity of products developed for critical health conditions.

Quality Assurance and Control

Analytical Development and Support

Leadership Team

Quality Assurance and Control

About

Team members